Respiratory Inhalers Market Worth US$ 42.99 billion by 2030 – Growth Plus Reports

Newark, New Castle, USA, March 02, 2023 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global respiratory inhalers market is expected to clock US$ 42.99 billion by 2030 and to grow at a CAGR of 6.1% during the forecast period. Owing to growing technological advancements, product launches, and regulatory approvals. This exclusive information is published by Growth Plus Reports in its report titled “Respiratory Inhalers Market – Global Outlook & Forecast 2022-2030”

The global respiratory inhaler market has been analysed from four different perspectives – Product Type, Patient Type, Indication, and Region.

Get a Free Sample Research Report:

Excerpts from ‘By Product Type Segmentation’

The respiratory inhaler market is segmented by product type into:

  • Dry Powder Inhalers
  • Metered Dosed Inhalers
  • Soft Mist Inhalers
  • Nebulizers

Nebulizers are further divided into jet nebulizers, ultrasonic nebulizers and mesh nebulizers. The metered dosed inhalers held major share of the market in 2021 as these are the most common type of inhalers which uses pressurized canisters to release medication in the form of a mist or aerosol.

MDIs can be used to deliver a variety of medications, including bronchodilators, corticosteroids, and combinations of these medications. They are widely used and considered a reliable and effective method for delivering medication to the lungs.

Another popular inhaler type is the dry powder inhaler (DPI) and are likely to grow at high CAGR during the forecast period. DPIs use a different mechanism to deliver medication to the lungs, where instead of using a pressurized canister, it uses a capsule or blister containing a dry powder form of the medication.

DPIs are typically used to deliver bronchodilators or corticosteroids and are considered to be a convenient alternative for some patients who have difficulty using MDIs. Nebulizers deliver medication in the form of a fine mist through a mask or mouthpiece, and can be used to deliver bronchodilators, corticosteroids, and other medications. They are also useful for younger children or older adults, who may have difficulty using other types of inhalers.

Recently, smart or digital inhalers are becoming increasingly popular, these are connected devices that can be used to track medication usage and provide feedback to patients and healthcare providers. They can also be integrated with mobile apps and other digital tools to improve medication adherence and help patients manage their condition.

Excerpts from ‘By Patient Type Segmentation’

The respiratory inhaler market based on patient type is segmented into:

  • Adult
  • Pediatric

One major patient segment is adult patients, who make up a significant portion of the market as they are at an increased risk of developing respiratory conditions such as asthma and COPD. Geriatric patients, particularly those over the age of 65, may have difficulty using certain types of inhalers, such as metered-dose inhalers, due to decreased dexterity or cognitive impairment. Geriatric patients may benefit from using dry powder inhalers or nebulizers, which may be easier to use.

Excerpts from ‘By Region Segmentation’

Based on the regional segmentation the global respiratory inhaler market is divided as:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

North America held the largest market share in 2021 for respiratory inhalers. The significant prevalence of CPOD in this area is promoting the expansion of the global inhaler market. The second-largest market for respiratory inhalers is Europe. The major market competitors are making a lot of efforts to boost the overall production in the region.

The market for respiratory inhalers is experiencing tremendous demand due to the growing awareness of CPOD and asthma. During the anticipated timeframe, the size of the European respiratory inhaler market will increase significantly.

Asia Pacific is the fastest-growing market for respiratory inhalers. More chances for the market expansion of respiratory inhalers are presented by the expanding healthcare infrastructure. The highest respiratory cases in this area are driving up demand for inhalers.  Government spending on health care and technological improvements are the main driving forces in this area.

Request for Customization –

Respiratory Inhalers Market Scope

Report Attribute Details
Market size value in 2021 US$ 25.23 billion
Revenue forecast in 2030 US$ 42.99 billion
Growth Rate CAGR of 6.1% from 2022 to 2030
Base year for estimation 2021
Forecast period 2022-2030
Historical Year 2020
Segments covered Product Type, Patient Type, Indication, And Region
Regional scope North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Excerpts from ‘Competitive landscape’

To meet the needs of a growing patient population, businesses in the respiratory inhaler devices market are pursuing strategic alliances with software and digital service providers. For instance, to create an integrated smart inhaler, Novartis worked with Qualcomm, a top U.S. mobile technology company. Some of the players are concentrating on establishing a niche for a particular demographic. For instance, OMRON introduced the WheezeScan device to help treat childhood asthma.
With this launch, the firm is making a step toward realizing its “Going For Zero” purpose, which calls for it to try to create a world free of heart attacks and strokes. Lupin has introduced a Bluetooth-enabled device with built-in sensors to monitor patients’ daily metered-dose inhaler usage patterns. Companies seek competitive advantage through these advancements. The key companies operating the global respiratory inhalers market are:

  • GlaxoSmithKline (GSK)
  • AstraZeneca
  • Boehringer Ingelheim
  • Novartis
  • Merck & Co.
  • Teva Pharmaceutical Industries
  • Sanofi
  • Mylan
  • Sunovion Pharmaceuticals
  • Hikma Pharmaceuticals
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Cipla Ltd.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Dry Powder Inhalers
    2. Metered Dosed Inhalers
    3. Soft Mist Inhalers
    4. Nebulizers
      1. Jet Nebulizers
      2. Ultrasonic Nebulizers
      3. Mesh Nebulizers
    1. Adult
    2. Pediatric 
    1. Asthma
    2. COPD
    3. Others

TOC Continued..

Directly Purchase Premium Copy of Respiratory Inhalers Market Growth Report (2022-2030) at:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst:

Visit our report store at –

Browse related reports:

Hospital Beds Market by Technology (Electric, Semmi-electric, Manual), Application (Acute Care, Psychiatric, Long-term Care), End-user (Hospitals, Home Care) – Global Outlook & Forecast 2023-2031

Graft Versus Host Diseases Market by Treatment Type (Immunosuppressants, Corticosteroids, mTOR Inhibitors, Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Others), Disease Type (Acute GVHD, Chronic GVHD, Prophylaxis GVHD) – Global Outlook & Forecast Period 2023-2031

Fundus Cameras Market by Product Type (Mydriatic Fundus Cameras, Non-Mydriatic Fundus Cameras, Hybrid Fundus Cameras), Modality (Handheld, Tabletop), End User (Hospitals, Ophthalmology Clinics) – Global Outlook & Forecast 2023-2031

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Market by Treatment (Corticosteroids, Intravenous Immunoglobulin (IVIG)), Distribution Channel (Retail Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031

Breath Analysers Market by Technology (Fuel Cell Technology, Semiconductor Sensor), by Application (Drug Abuse Detection, Alcohol Detection) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.